Explorer les evidences

0 %Vaccination acceptance against the SARS-CoV-2 virus among sickle-cell subjects in Franceville, Gabon was 0%.

GabonCOVID-19 · drépanocytosepublié 2023South Asian Research Journal of Applied Medical SciencesOpenAlexdocument de 4 observations

COVID-19 positive samples were collected in Gabon between March 2020 and October 2021.

GabonCOVID-19observé March 2020 to October 2021publié 2022PLoS neglected tropical diseaseseurope_pmcdocument de 3 observationsDOI 10.1371/journal.pntd.0010964

In infants (0–9 months), children (1–17 years) and adults, the prevalence of neutralizing antibodies against SARS-CoV-2 was between 25% and 28.6%.

GabonCOVID-19publié 2021BMC Research NotesOpenAlexdocument de 7 observationsDOI 10.1186/s13104-021-05570-3

8 patientsAll 8 patients with malaria and COVID-19 co-infection were febrile.

GabonCOVID-19 · paludismepublié 2022The Pan African medical journalPubMeddocument de 6 observations

3,8 %The elderly accounted for 3.8% of SARS-CoV-2 positive persons.

GabonCOVID-19publié 2021Scientific reportseurope_pmcdocument de 23 observations

495 casesOver 1 year in 2020, 495 COVID-19 cases (RT-PCR positive) were recruited at the Regional Hospital of Lambaréné in Gabon.

GabonCOVID-19observé 2020publié 2022Medecine tropicale et sante internationalePubMeddocument de 6 observations

3,9 %Diabetes was present in 11 of 282 patients (3.9%) with mild COVID-19 symptoms.

GabonCOVID-19 · diabète (non précisé)observé March to June 2020publié 2021JAMA network openPubMeddocument de 10 observations

6,1 %Malaria and COVID-19 co-infections were diagnosed in 3 (6.1%) patients among febrile patients screened in Gabon from October 2021 to December 2021.

GabonCOVID-19 · paludismeobservé October 2021 to December 2021publié 2022Southern African journal of infectious diseaseseurope_pmcdocument de 4 observations

20 copiesThe RT-LAMP assay successfully detected 20–50 copies of the SARS-CoV-2 viral genome within 15 minutes, regardless of the variant.

GabonCOVID-19publié 2022PLoS neglected tropical diseaseseurope_pmcdocument de 3 observationsDOI 10.1371/journal.pntd.0010964

62,6 %Among 837 patients with COVID-19 in Gabon from March to June 2020, 524 (62.6%) were asymptomatic, 282 (33.7%) had mild symptoms, and 31 (3.7%) had severe symptoms.

GabonCOVID-19observé March to June 2020publié 2021JAMA network openPubMeddocument de 10 observations

92 %The seroprevalence of SARS-CoV-2 antibodies in Ogooué-Lolo province in Gabon was 92%.

GabonCOVID-19observé up to December 2021publié 2024Viruseseurope_pmcdocument de 5 observations

188 patientsAmong 305 surveyed patients with COVID-19, 188 (62%) were taking QT-prolonging drugs, which prohibited administration of hydroxychloroquine.

GabonCOVID-19publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 8 observations

53,4 yearsPatients with severe COVID-19 symptoms and a fatal outcome had a mean age of 53.4 years (SD 15.1 years), compared to 41.5 years (SD 12.9 years) for survivors.

GabonCOVID-19observé March to June 2020publié 2021JAMA network openPubMeddocument de 10 observations

98,1 %Almost all participants (98.1%) said that they had heard about COVID-19.

GabonCOVID-19publié 2021Knowledge, Attitude, and Practice During the COVID-19 Pandemic in South-east Gabon.europe_pmcdocument de 11 observationsDOI 10.21203/rs.3.rs-299801/v1

54,7 %Middle-aged adults accounted for 54.7% of SARS-CoV-2 positive persons.

GabonCOVID-19publié 2021Scientific reportseurope_pmcdocument de 23 observations

72,8 %The seroprevalence of SARS-CoV-2 antibodies in Nyanga province, Gabon, was 72.8%.

GabonCOVID-19observé up to December 2021publié 2024SARS-CoV-2 Antibody Seroprevalence in Gabon: Findings from the Nationwide Household Serosueurope_pmcdocument de 6 observations

173 194 genomesThe study analysed 173,194 SARS-CoV-2 genomes from the GISAID database to explore variant distribution across Africa between 2020 and 2024.

GabonCOVID-19observé 2020 and 2024publié 2026Viruseseurope_pmcdocument de 5 observations

20,9 %Only 20.9% of respondents thought that vaccination can protect them against COVID-19.

GabonCOVID-19publié 2021Knowledge, Attitude, and Practice During the COVID-19 Pandemic in South-east Gabon.europe_pmcdocument de 11 observationsDOI 10.21203/rs.3.rs-299801/v1

72,8 %The seroprevalence of SARS-CoV-2 antibodies in Nyanga province in Gabon was 72.8%.

GabonCOVID-19observé up to December 2021publié 2024Viruseseurope_pmcdocument de 5 observations

31,4 %The prevalence of polymerase chain reaction-defined SARS-CoV-2 was 31.4% among 277 participants tested in Sindara and Lambaréné, Gabon, from August 2021 to February 2022.

GabonCOVID-19observé August 2021 to February 2022publié 2025The American journal of tropical medicine and hygieneeurope_pmcdocument de 10 observations

305 patientsA retrospective survey of 305 patients with COVID-19 found that 279 (92%) were not eligible for a hydroxychloroquine clinical trial mainly due to safety concerns caused by health conditions or co-medications.

GabonCOVID-19publié 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument de 8 observations

8 %The lowest rate of infection (8%) was observed in the elderly (aged > 60).

GabonCOVID-19publié 2021Scientific reportseurope_pmcdocument de 23 observations

20 %The rate of SARS-CoV-2 infection in both young (18–35 years old) and middle-aged adults (36–60 years old) was around 20%.

GabonCOVID-19publié 2021Scientific reportseurope_pmcdocument de 23 observations

0,1 %Among 809 SARS-CoV-2 samples screened by qRT-PCR in Gabon from March 2020 to September 2021, one (0.1%) was classified as VOC Beta (B.1.351).

GabonB.1.351 · COVID-19 · VOC Betaobservé March 2020 to September 2021publié 2022Frontiers in medicineeurope_pmcdocument de 13 observationsDOI 10.3389/fmed.2022.877391

39 %Early in the pandemic, men exhibited a 39% higher risk of infection compared to women.

GabonCOVID-19observé early in the pandemicpublié 2026Viruseseurope_pmcdocument de 5 observations